Search
News
UTI Fiscal Q3 2026 Earnings: Enrollment Growth Comes With Lower Profit
Universal Technical Institute’s fiscal Q3 2026 revenue rose 7.2% to $218.9 million, supported by a 10.9% increase in new student starts. Diluted EPS fell to $0.04 from $0.19, while adjusted EBITDA declined 27.8% to $18.2 million as strategic growth investments weighed on profitability. UTI lowered its fiscal 2026 revenue, earnings, adjusted EBITDA, and adjusted free cash flow guidance, citing fourth-quarter enrollment timing and mix. Nine-month adjusted free cash flow was negative $65.6 million amid elevated campus and program spending.
TradingKey
Wed, Aug 5
Honeywell Aerospace Q2 2026 earnings: Sales rise 5% as profit declines
Honeywell Aerospace’s Q2 2026 revenue rose 5% year over year to $4.52 billion, while GAAP diluted EPS fell 71% to $0.78 and adjusted EBIT declined 7% to $995 million. Commercial Aftermarket led end-market growth, but supply constraints, unfavorable mix, higher costs, and roughly $100 million of separation-related and inventory obsolescence charges pressured profitability. The company lowered full-year organic growth guidance to 4%-5% and pro forma standalone adjusted EBIT guidance to $4.35-$4.45 billion, while maintaining second-half free cash flow guidance of $1.0-$1.5 billion.TradingKey
Wed, Aug 5
Hamilton Beach Q2 2026 Earnings: Tariff Refunds Drive the Margin Surge
Hamilton Beach Brands Holding Company (NYSE: HBB) reported Q2 2026 revenue of $142.6 million, up 11.6%, and diluted EPS of $2.49 versus $0.33 a year earlier. Reported gross margin reached 54.3%, but one-time IEEPA tariff refunds and related inventory benefits were the main driver; excluding them, margin would have been 26.1%. The company reiterated its mid-single-digit 2026 revenue growth outlook, improved its gross-margin and operating-profit guidance, and maintained a $35 million to $45 million outlook for operating cash flow less investing activities.
TradingKey
Wed, Aug 5
Raytech fiscal 2026 earnings: New services lift revenue and margins
Raytech (Nasdaq: RAY) reported fiscal 2026 revenue of HK$142.6 million, up 81.1%, and net income of HK$16.7 million, up 101.9%. New design, advisory and marketing services contributed HK$44.2 million, or 31.0% of revenue, helping lift operating margin to 12.6% from 9.7%. Diluted EPS nevertheless declined to HK$7.19 from HK$7.60 as the weighted share count expanded. Operating cash flow was negative HK$14.5 million because of a year-end receivables buildup, although the company said those receivables were subsequently collected in full.
TradingKey
Wed, Aug 5
Brookfield Asset Management Q2 2026 Earnings: Fee-Related Earnings Rise 20%
Brookfield Asset Management (BAM) reported Q2 2026 revenue of US$1.75 billion, up about 61% from US$1.09 billion, while diluted GAAP EPS increased to US$0.56 from US$0.38. Fee-related earnings rose 20% to US$808 million and distributable earnings advanced 15% to US$707 million, supported by record quarterly fundraising and 19% growth in fee-bearing capital. A favorable carried-interest swing amplified GAAP growth, while credit supplied most of the quarter’s US$77 billion of fundraising.TradingKey
Wed, Aug 5
Global Indemnity Q2 2026 earnings: Premium growth meets higher expense pressure
Global Indemnity Group’s Q2 2026 total revenue increased about 5% to $116.1 million, and diluted EPS rose to $0.76 from $0.71. Net income reached $11.1 million, while Belmont Core gross written premiums grew 6.8% to $117.3 million, led by Assumed Reinsurance. Underwriting results were mixed: the loss ratio improved to 53.8%, but a higher expense ratio pushed the combined ratio to 95.0%. Non-GAAP operating income fell to $8.7 million, and book value per share declined to $48.28.
TradingKey
Wed, Aug 5
UroGen Q2 2026 Earnings: ZUSDURI Launch Nearly Triples Revenue
UroGen Pharma (URGN) reported Q2 2026 revenue of $72.5 million, up approximately 199% year over year, as ZUSDURI contributed $50.4 million during its commercial launch. Gross margin rose to about 90.9%, and the company reached a small $0.1 million operating profit, but financing, interest and tax expenses left a $14.4 million net loss, or $0.28 per share. UroGen also raised 2026 operating-expense guidance to $260 million-$270 million while maintaining JELMYTO revenue guidance of $97 million-$101 million.
TradingKey
Wed, Aug 5
Atlanta Braves Holdings Q2 2026 earnings: Baseball cost growth drives an operating loss
Atlanta Braves Holdings’ Q2 2026 revenue fell 2% to $305.1 million, while diluted EPS swung to a $0.19 loss from a $0.46 profit. Operating results weakened more sharply: the company posted an $18.5 million operating loss and Adjusted OIBDA fell 82% to $11.8 million. Six fewer home games reduced baseball event revenue, while media revenue also declined. Higher player salaries, BravesVision production and marketing costs, special-event expenses, and MLB shared costs pressured profitability, partly offset by 14% growth in Mixed-Use Development revenue. Debt also rose during the quarter to support seasonal working capital.
TradingKey
Wed, Aug 5
SmartRent Q2 2026 earnings: Gross margin expansion turns adjusted EBITDA positive
SmartRent’s Q2 2026 revenue rose 4% to $39.8 million, while Core Revenue increased 14% to $38.4 million. Gross margin expanded 760 basis points to 40.7%, and adjusted EBITDA improved to positive $0.7 million from a $7.3 million loss. The GAAP net loss narrowed 48% to $5.6 million, or $0.03 per diluted share. SaaS growth and professional-services installations offset lower hardware revenue, while booked units nearly doubled. SmartRent ended June with $92.7 million in cash, no debt, and an undrawn $75 million credit facility.
TradingKey
Wed, Aug 5
Rand Capital Q2 2026 Earnings: Non-Accruals Reduce Investment Income
Rand Capital’s Q2 fiscal 2026 total investment income fell 13% to $1.4 million as non-accrual investments reduced interest income and portfolio yield. Adjusted net investment income declined to $0.24 per share from $0.33, while a $959,000 realized gain from the Applied Image exit supported the overall increase in net assets from operations. The portfolio reached $56.5 million in fair value, and NAV was $17.33 per share at June 30, 2026, as new deployment lowered cash and increased credit-line borrowings.
TradingKey
Wed, Aug 5
Trinity Capital Q2 2026 earnings: Investment income rises while per-share NII slips
Trinity Capital (NYSE: TRIN) reported Q2 2026 total investment income of $87.2 million, up 25.5% year over year, and record net investment income of $46.0 million. Diluted NII per share slipped to $0.51 from $0.53 as the weighted average share count increased, while interest expense rose to $24.8 million. The portfolio reached about $2.7 billion in fair value, NAV increased sequentially to $13.47 per share, and available liquidity ended the quarter at $430.1 million with net leverage at 118%.TradingKey
Wed, Aug 5
Avnet Fiscal Q4 2026 Earnings: Record Sales Lift Operating Margins
Avnet’s fiscal Q4 2026 revenue reached a record $8.30 billion, up 47.7% year over year, while diluted EPS increased to $1.49 from $0.07. Adjusted operating margin expanded 129 basis points to 3.8%, with Electronic Components revenue up 49.0% and Farnell revenue up 29.4%. Fiscal 2026 operating cash flow was negative $280.9 million as receivables and inventory absorbed cash. Avnet guided fiscal Q1 2027 sales to $9.00-$9.30 billion and adjusted diluted EPS to $2.80-$2.90, implying approximately 10% sequential sales growth at the revenue midpoint.
TradingKey
Wed, Aug 5
OSS Q2 2026 Earnings: Revenue Rose 62% as a Legal Settlement Widened the Loss
One Stop Systems (OSS) reported Q2 2026 revenue from continuing operations of $9.3 million, up 62.3% year over year, while diluted EPS fell to a loss of $0.29 from $0.11. A $6.25 million legacy legal settlement drove the wider GAAP loss, but non-GAAP EPS improved to a loss of $0.01 and adjusted EBITDA loss narrowed to $0.3 million. Record bookings of $15.1 million supported raised full-year revenue growth guidance of 25%-30%, while gross margin declined to 39.1% because of product mix and early-stage program work.
TradingKey
Wed, Aug 5
Holley Q2 2026 Earnings: Core Sales Rise as a Divestiture Charge Drives a GAAP Loss
Holley’s Q2 2026 net sales rose 3.2% to $172.0 million, while core business sales increased 4.9%. GAAP diluted EPS fell to $(0.02) from $0.09 as a $28.3 million loss on the sale of non-core assets pushed the company to a $2.4 million net loss. Adjusted EBITDA declined to $33.8 million and margin narrowed to 19.6%, but free cash flow improved to $40.9 million. Holley reiterated its full-year 2026 outlook, including net sales of $610 million to $640 million.
TradingKey
Wed, Aug 5
Bioventus Q2 2026 Earnings: Pain Treatments Drive 4% Revenue Growth
Bioventus reported Q2 2026 revenue of $153.2 million, up 3.8% year over year, and GAAP diluted EPS of $0.47 versus $0.11. Pain Treatments revenue rose 11.5% and offset declines in Surgical Solutions and Restorative Therapies. A $24.6 million deferred-tax valuation allowance release drove much of the GAAP earnings increase, while adjusted EPS edged up to $0.22 and operating cash flow fell to $19.9 million. Bioventus reaffirmed its 2026 guidance while initiating a review of strategic alternatives.
TradingKey
Wed, Aug 5
Medline Q2 2026 earnings: Sales grew while fire losses pressured profit
Medline’s Q2 2026 net sales rose 11.6% to $7.685 billion, while net income fell 58.3% to $139 million and adjusted EBITDA increased 13.4% to $1.06 billion. Existing-customer growth and implementation of 2025 customer wins supported revenue, but a $336 million loss from the Tracy distribution-center fire, higher operating expenses and tariff-related costs weighed on GAAP profit. A net IEEPA tariff refund benefit also lifted quarterly results, while Medline raised organic sales guidance and lowered its adjusted EBITDA outlook for full-year 2026.
TradingKey
Wed, Aug 5
XPEL Q2 2026 Earnings: Record Revenue and a Wider Gross Margin
XPEL’s Q2 2026 revenue rose 14.7% year over year to a record $143.1 million, while diluted EPS increased to $0.65 from $0.59. Gross margin expanded to 44.1% from 42.9%, supporting 20.7% growth in adjusted EBITDA to $28.3 million. China-led Asia Pacific growth was the main geographic driver, while two other international regions declined. Operating cash flow reached $30.8 million, but manufacturing investments lifted investing outflows to $72.9 million. XPEL guided Q3 revenue to approximately $137 million to $139 million.
TradingKey
Wed, Aug 5
Gibraltar Q2 2026 earnings: OmniMax drives sales growth, but EPS declines
Gibraltar Industries’ Q2 2026 continuing-operations revenue rose 64.6% to $509.5 million, driven largely by OmniMax, while organic growth was 5%. GAAP diluted EPS fell 7.1% to $0.92 and adjusted EPS slipped 1.8% to $1.11 as higher interest expense and integration-related costs offset the increase in scale. Adjusted EBITDA climbed 59.7% to $88.0 million. Residential produced 83% of quarterly revenue, Agtech margins improved, and Infrastructure weakened. Gibraltar reiterated its full-year 2026 outlook while continuing OmniMax integration and synergy work.
TradingKey
Wed, Aug 5
Griffon Fiscal Q3 2026 Earnings: Revenue Rises 7% as Margins Narrow
Griffon Corporation’s fiscal Q3 2026 revenue rose 7% to $481.4 million, driven mainly by 6% favorable price and mix, while adjusted EPS from continuing operations increased to $1.51 from $1.39. Adjusted EBITDA advanced 2% to $124.8 million, but gross and adjusted EBITDA margins narrowed as material and SG&A costs increased. The company ended June with 2.2x net leverage, projected fiscal 2026 revenue of $1.8 billion and adjusted EBITDA of $458 million, and substantially completed its shift to a pure-play building products company.
TradingKey
Wed, Aug 5
DISCO Q2 2026 Earnings: Revenue Grows as GAAP Loss Narrows
DISCO’s Q2 2026 revenue rose 13% to $43.1 million, while GAAP net loss narrowed to $8.7 million from $10.8 million and loss per share improved to $0.13 from $0.18. However, adjusted EBITDA deteriorated to a $3.4 million loss from $2.7 million as underlying operating costs remained elevated. Software revenue reached $36.8 million, and customers generating more than $100,000 over the trailing 12 months increased 10% to 354. Q3 guidance calls for $43.75 million to $45.75 million in total revenue and a smaller adjusted EBITDA loss.
TradingKey
Wed, Aug 5
Featured Tools
Top News
Meta Q3 Net Profit Surges 264% YoY, Raises Full-Year Capex Slightly; Shares Briefly Rise Over 4% After Hours
Tesla Q3 Operating Profit Plunges 56% YoY, Dragged Down by Higher Operating Expenses Including R&D
US Stocks Close: Nasdaq Gains Over 1%, Philadelphia Semiconductor Index Rises Nearly 2%; Tech Stocks Strengthen, SpaceX Gains Nearly 8% Post-Earnings
Meta Q3 2026 Earnings: Legal Charge Halves Operating Margin Despite 26% Revenue Growth
Meta Q3 2026 Earnings Call: Ad Growth, Muse AI and Q4 Guidance
